Drugs used to treat joint and muscle disease. Issue 1 (January 2021)

• Record Type: Journal Article
• Authors: de Gray, Lorraine E.; Seth, Bharti
• Is Part Of: Anaesthesia and intensive care medicine. Volume 22:Issue 1(2021)
• Page Start: 70
• Page End: 76
• Publication Date: 2021-01
• Subjects: Degenerative -- immune mediated -- inflammation -- joints -- metabolic -- muscles -- pain -- spasm -- spasticity -- traumatic; Anesthesiology -- Periodicals; Critical care medicine -- Periodicals; Anesthesia -- Periodicals; Intensive care -- Periodicals; Electronic journals; Periodicals; 617.9605
• DOI: 10.1016/j.mpaic.2020.11.001
• Languages: English
• ISSNs: 1472-0299

Abstract

Abstract: Musculoskeletal disorders have a very diverse aetiology. They have a significant impact on each individual sufferer's quality of life and society as a whole. The last three decades have seen revolutionary changes in the management of autoimmune-related muscle and joint disorders due to the introduction of biologics. Management of spasticity disorders remain challenging, although implantable technology has broadened mode of delivery.